This is a preview of subscription content, log in via an institution to check access.
Reference
Retel VP, et al. Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial. European Journal of Cancer 137: 193-203, 11 Aug 2020. Available from: URL: http://doi.org/10.1016/j.ejca.2020.07.002
Rights and permissions
About this article
Cite this article
70-gene signature cost effective in guiding breast cancer therapy. PharmacoEcon Outcomes News 861, 1 (2020). https://doi.org/10.1007/s40274-020-7083-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7083-z